相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel
Ho Yub Yoon et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
The immunotherapeutic effects of recombinant Bacillus Calmette-Guerin resistant to antimicrobial peptides on bladder cancer cells
Min-Ji Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guerin induce antitumor immunity in a syngeneic murine bladder cancer model
Takayuki Yoshino et al.
PLOS ONE (2019)
Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer
Sally A. Sabra et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology
Hideyuki Masuda et al.
MOLECULAR PHARMACEUTICS (2018)
Docetaxel-loaded RIPL peptide (IPIANPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy
Ho Yub Yoon et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer
Chi-Ping Huang et al.
CYTOTHERAPY (2017)
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Andreas Wicki et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Design of Multifunctional Liposomal Nanocarriers for Folate Receptor-Specific Intracellular Drug Delivery
Min Hyung Kang et al.
MOLECULAR PHARMACEUTICS (2015)
Nanoparticulation of BCG-CWS for application to bladder cancer therapy
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model
Takashi Nakamura et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Assessment of PEG on polymeric particles surface, a key step in drug carrier translation
Jean-Michel Rabanel et al.
JOURNAL OF CONTROLLED RELEASE (2014)
The mechanism of action of BCG therapy for bladder cancer-a current perspective
Gil Redelman-Sidi et al.
NATURE REVIEWS UROLOGY (2014)
The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers
Shrikant Thakur et al.
JOURNAL OF NANOPARTICLE RESEARCH (2013)
Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: Conformational characterization and cellular uptake evaluation
Myung J. Kang et al.
JOURNAL OF DRUG TARGETING (2011)
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial
Savino M. Di Stasi et al.
LANCET ONCOLOGY (2011)
Bladder Cancer in 2010 How Far Have We Come?
Bruce L. Jacobs et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer
Anton B. Alexandroff et al.
IMMUNOTHERAPY (2010)
Size and shape effects in the biodistribution of intravascularly injected particles
P. Decuzzi et al.
JOURNAL OF CONTROLLED RELEASE (2010)
PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation
Saijie Zhu et al.
PHARMACEUTICAL RESEARCH (2010)
Evaluation of Docetaxel-Loaded Intravenous Lipid Emulsion: Pharmacokinetics, Tissue Distribution, Antitumor Activity, Safety and Toxicity
Mingming Zhao et al.
PHARMACEUTICAL RESEARCH (2010)
Morphological study on Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105)
Yuko Uenishi et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2009)
Innate immune therapy with a Bacillus Calmette-Gu,rin cell wall skeleton after radical surgery for non-small cell lung cancer: A case-control study
Ken Kodama et al.
SURGERY TODAY (2009)
Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes
Guangya Xiang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers
Justin M. Saul et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
RFM Bevers et al.
BRITISH JOURNAL OF CANCER (2004)
Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation
H Suttmann et al.
JOURNAL OF UROLOGY (2004)
Development of immunoadjuvants for immunotherapy of cancer
I Azuma et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Folate-mediated targeting: from diagnostics to drug and gene delivery
CP Leamon et al.
DRUG DISCOVERY TODAY (2001)
分享论文
